Suchergebnisse - "Fu, Chengcheng"

PubPharm (5)

1

Which one is better for refractory/relapsed acute B-cell lymphoblastic leukemia : Single-target (CD19) or dual-target (tandem or sequential CD19/CD22) CAR T-cell therapy?

enthalten in: Blood cancer journal | 2023

von Liu, S. | Zhang, X. | Dai, H. | +19

2

Chimeric antigen receptors containing the OX40 signalling domain enhance the persistence of T cells even under repeated stimulation with multiple myeloma target cells

enthalten in: Journal of hematology & oncology | 2022

von Tan, J. | Jia, Y. | Zhou, M. | +24

3

Sequential CD19 and BCMA-specific CAR T-cell treatment elicits sustained remission of relapsed and/or refractory myeloma

enthalten in: Cancer medicine | 2021

von Yan, L. | Qu, S. | Shang, J. | +14

4

Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells

enthalten in: American journal of hematology | 2020

von Yan, L. | Shang, J. | Shi, X. | +11

5

Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation

enthalten in: Hematological oncology | 2019

von Yang, X. | Dai, H. | Kang, L. | +12

1
[1]